CWM
EDIT icon

Catamount Wealth Management’s Editas Medicine EDIT Stock Holding History

Catamount Wealth Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$4K Sell
150
-150
-50% -$3.4K ﹤0.01% 163
2018
Q4 		$7K Hold
300
– – ﹤0.01% 144
2018
Q3 		$10K Hold
300
– – ﹤0.01% 144
2018
Q2 		$9K Sell
300
-150
-33% -$5.31K ﹤0.01% 146
2018
Q1 		$15K Buy
450
+225
+100% +$8.02K 0.01% 123
2017
Q4 		$7K Buy
225
+175
+350% +$4.41K ﹤0.01% 145
2017
Q3 		$1K Buy
+50
New +$952 ﹤0.01% 183

Other funds holding EDIT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return

Catamount Wealth Management's EDIT Position: Q1 2019 in Review

Catamount Wealth Management reduced its Editas Medicine (EDIT) stake by 50% in Q1 2019, selling an estimated $3.4K and leaving 150 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #163.

Catamount Wealth Management first reported a position in EDIT in Q3 2017 and has held it in 7 quarters since. The position peaked at $15K in Q1 2018. 201 funds tracked by Wall St. Rank hold EDIT as of Q1 2019.

  • Catamount Wealth Management held 150 shares of Editas Medicine worth $4K as of Q1 2019.
  • Catamount Wealth Management sold 150 Editas Medicine shares in Q1 2019, an estimated $3.4K.
  • Editas Medicine made up ﹤0.01% of Catamount Wealth Management's portfolio in Q1 2019, its #163 holding.
  • Catamount Wealth Management first reported a position in Editas Medicine in Q3 2017 and has held it in 7 quarters since.
  • Catamount Wealth Management's Editas Medicine position peaked at $15K in Q1 2018.
  • 201 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2019.

Based on Catamount Wealth Management's 13F filing for Q1 2019, filed 3 May 2019.